|
The reported event involved clinical deterioration following implantation of a sophysa spv valve, leading to device replacement.During the complaint investigation, it was determined that the returned device was a spv valve and not a spv-140 valve as initially reported.Device identification was confirmed through analysis of the returned product.Device investigation revealed obstruction of the valve mechanism and elevated operating pressures at all programmable settings, consistent with an under-drainage condition.Blood-stained fluid and physiological residues were observed inside the valve.Manufacturing history review confirmed that the device met all release specifications, and dimensional inspection did not identify any manufacturing-related deficiency or design anomaly.Based on the available evidence, the most probable root cause of the malfunction is obstruction of the valve mechanism by physiological material (blood products and/or tissue debris) accumulated during clinical use.This obstruction likely interfered with normal valve operation, resulting in increased operating pressures and reduced cerebrospinal fluid drainage.No evidence of manufacturing defect was identified.The reported event is therefore attributed to in vivo obstruction of the valve by physiological material.
|